Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and indium tris(tropolonate)

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with indium tris(tropolonate) in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(indium tris(tropolonate))
Trials
(indium tris(tropolonate))
Recent Studies (post-2010) (indium tris(tropolonate))
9,1561875526420

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clague, J; Dixon, CM; Henderson, BL; Ind, PW; Lavender, JP; Peters, AM; Stuttle, AW; Tam, FW1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and indium tris(tropolonate)

ArticleYear
Inhaled platelet-activating factor causes pulmonary neutrophil sequestration in normal humans.
    The American review of respiratory disease, 1992, Volume: 146, Issue:4

    Topics: Administration, Inhalation; Adult; Blood Platelets; Bronchial Provocation Tests; Erythrocytes; Humans; Indium Radioisotopes; Lung; Male; Neutrophils; Organometallic Compounds; Platelet Activating Factor; Platelet Count; Radionuclide Imaging; Technetium; Time Factors; Tropolone

1992